SynthesisJournal of translational medicine2025

KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors.

Linyan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.